Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Más filtros

Banco de datos
Tipo del documento
Publication year range
1.
Rinsho Shinkeigaku ; 64(7): 490-495, 2024 Jul 27.
Artículo en Japonés | MEDLINE | ID: mdl-38910116

RESUMEN

A 43-year-old man was admitted to our department due to fever and headache. The cerebrospinal fluid analysis confirmed bacterial meningitis. Campylobacter species were isolated from blood cultures on the third day of admission. The patient was treated with meropenem (MEPM) and discharged on the 17th day. However, he experienced a recurrence of meningitis and was readmitted on the 68th day, initiating MEPM therapy. Campylobacter fetus was isolated from cerebrospinal fluid cultures on the 74th day. MEPM was continued until the 81st day, followed by one month of minocycline (MINO) therapy. The patient had an uneventful recovery without further recurrence. This case highlights the potential for recurrence of Campylobacter fetus meningitis approximately two months after the resolution of the initial infection. In addition to carbapenem therapy for at least two weeks, the adjunctive administration of MINO may be beneficial.


Asunto(s)
Antibacterianos , Infecciones por Campylobacter , Campylobacter fetus , Meningitis Bacterianas , Meropenem , Minociclina , Recurrencia , Humanos , Masculino , Adulto , Campylobacter fetus/aislamiento & purificación , Infecciones por Campylobacter/tratamiento farmacológico , Infecciones por Campylobacter/complicaciones , Infecciones por Campylobacter/diagnóstico , Infecciones por Campylobacter/microbiología , Meropenem/administración & dosificación , Meningitis Bacterianas/tratamiento farmacológico , Meningitis Bacterianas/microbiología , Meningitis Bacterianas/diagnóstico , Antibacterianos/administración & dosificación , Factores de Tiempo , Minociclina/administración & dosificación , Resultado del Tratamiento , Tienamicinas/administración & dosificación , Quimioterapia Combinada
2.
Redox Biol ; 36: 101616, 2020 09.
Artículo en Inglés | MEDLINE | ID: mdl-32863225

RESUMEN

Asbestos is still a social burden worldwide as a carcinogen causing malignant mesothelioma. Whereas recent studies suggest that local iron reduction is a preventive strategy against carcinogenesis, little is known regarding the cellular and molecular mechanisms surrounding excess iron. Here by differentially using high-risk and low-risk asbestos fibers (crocidolite and anthophyllite, respectively), we identified asbestos-induced mutagenic milieu for mesothelial cells. Rat and cell experiments revealed that phagocytosis of asbestos by macrophages results in their distinctive necrotic death; initially lysosome-depenent cell death and later ferroptosis, which increase intra- and extra-cellular catalytic Fe(II). DNA damage in mesothelial cells, as assessed by 8-hydroxy-2'-deoxyguanosine and γ-H2AX, increased after crocidolite exposure during regeneration accompanied by ß-catenin activation. Conversely, ß-catenin overexpression in mesothelial cells induced higher intracellular catalytic Fe(II) with increased G2/M cell-cycle fraction, when p16INK4A genomic loci localized more peripherally in the nucleus. Mesothelial cells after challenge of H2O2 under ß-catenin overexpression presented low p16INK4A expression with a high incidence of deletion in p16INK4A locus. Thus, crocidolite generated catalytic Fe(II)-rich mutagenic environment for mesothelial cells by necrotizing macrophages with lysosomal cell death and ferroptosis. These results suggest novel molecular strategies to prevent mesothelial carcinogenesis after asbestos exposure.


Asunto(s)
Amianto , Ferroptosis , Mesotelioma , Animales , Epitelio , Compuestos Ferrosos , Peróxido de Hidrógeno , Macrófagos , Mutágenos , Ratas , beta Catenina/genética
SELECCIÓN DE REFERENCIAS
Detalles de la búsqueda